Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors
NCT05997056Phase 2Completed
- Sponsor
- Aadi Bioscience, Inc.
- Start
- Oct 2023
- Primary completion
- Oct 2025
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-sirolimus in Neuroendocrine Neoplasm (NEN), sponsored by Aadi Bioscience, Inc.. Started Oct 2023; status: completed.
02
Drugs
nab-sirolimus
03
Conditions
Neuroendocrine Neoplasm (NEN)
Beyond the preview
Go deeper on NCT05997056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05997056.